The Oncology Shot with Timothee Olivier
Substacknewsletter · by Timothée Olivier · English
My Personal Substack
- Audience
- 7K subscribers
- Shown publicly on Substack
- Observed frequency
- Weekly
- From 9 posts indexed in the last 90 days
- Last post
- Nov 11, 2026
- 6 days ago
- Likely audience
- Oncologists
- Inferred from post content
The Oncology Shot with Timothee Olivier is a Substack newsletter by Timothée Olivier covering Oncology clinical trials, daraxonrasib pancreatic cancer treatment and RASolute 302 clinical trial results. NewsletterFIT indexed 9 posts from it in the last 90 days, most recently on Nov 11, 2026. Shown publicly on Substack: 7K subscribers.
Topics
- Oncology clinical trials
- daraxonrasib pancreatic cancer treatment
- RASolute 302 clinical trial results
- RAS(ON) inhibitors
- radiotherapy clinical trials in pancreatic cancer
Recent posts
- Do we…
- Currency of…
- My MD-Anderson…
- Not One,…
- What to…
- The forgotten…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on The Oncology Shot with Timothee Olivier
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
The Oncology Shot with Timothee Olivier alternatives: similar newsletters
Ranked by how many topics they share with The Oncology Shot with Timothee Olivier.
SubstackMonthly or less · last post Sep 3, 2026
Likely audience: Biotech investors
1 shared topic
Compiled from public pages · refreshed Nov 16, 2026 · How NewsletterFIT collects and labels data
